Orilanolimab (Anti-FcRn (FCGRT & B2M))

Ask supplier a question | View on supplier's website

Orilanolimab (Anti-FcRn (FCGRT & B2M)) is a humanized monoclonal antibody targeting FcRn. It disrupts the interaction of FcRn and IgG for the treatment autoimmune diseases. MW :144.28 KD.

Supplier	Selleck Chemicals
Product #	A3000
Sku #	A3000-1mg
Pricing	1mg, $570.00

Feedback